• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Am Geriatr Soc . PREDICTING IN-HOSPITAL MORTALITY IN COVID-19 OLDER PATIENTS WITH SPECIFICALLY DEVELOPED SCORES

tetano

Editor, Senior Moderator
J Am Geriatr Soc


. 2020 Nov 16.
doi: 10.1111/jgs.16956. Online ahead of print.
PREDICTING IN-HOSPITAL MORTALITY IN COVID-19 OLDER PATIENTS WITH SPECIFICALLY DEVELOPED SCORES


Marcello Covino[SUP] 1 [/SUP], Giuseppe De Matteis[SUP] 2 [/SUP], Maria Livia Burzo[SUP] 2 [/SUP], Andrea Russo[SUP] 3 [/SUP], Evelina Forte[SUP] 1 [/SUP], Annamaria Carnicelli[SUP] 1 [/SUP], Andrea Piccioni[SUP] 1 [/SUP], Benedetta Simeoni[SUP] 1 [/SUP], Antonio Gasbarrini[SUP] 4 5 [/SUP], Francesco Franceschi[SUP] 1 5 [/SUP], Claudio Sandroni[SUP] 6 5 [/SUP], GEMELLI AGAINST COVID-19 Group



Collaborators, Affiliations

Abstract

Background/objectives: Several scoring systems have been specifically developed for risk stratification in COVID-19 patients.
Design: We compared, in a cohort of confirmed COVID-19 older patients, three specifically developed scores with a previously established early warning score. Main endpoint was all causes in-hospital death.
Setting: This is a single-center, retrospective observational study, conducted in the Emergency Department (ED) of an urban teaching hospital, referral center for COVID-19.
Measurements: International Severe Acute Respiratory Infection Consortium Clinical Characterization Protocol-Coronavirus Clinical Characterization Consortium (ISARIC-4C) score, COVID-GRAM Critical Illness Risk Score (COVID-GRAM), quick COVID-19 Severity Index (qCSI), National Early Warning Score (NEWS).
Participants: We reviewed the clinical records of the confirmed COVID-19 patients aged ≥60 years consecutively admitted to our ED over a six-week period (March 1st to April 15th, 2020). A total of 210 patients, aged between 60 and 98 years were included in the study cohort.
Results: Median age was 74 [67-82] and 133 (63.3%) were males. Globally, 42 patients (20.0%) deceased. All the score evaluated showed a fairly good predictive value with respect to in-hospital death. The ISARIC-4C score had the highest area under ROC curve (AUROC) 0.799 [0.738-0.851], followed by the COVID-GRAM 0.785 [0.723-0.838], NEWS 0.764 [0.700-0.819] and qCSI 0.749 [0.685-0.806]. However, these differences were not statistical significant.
Conclusions: Among the evaluated scores, the ISARIC-4C and the COVID-GRAM, calculated at ED admission, had the best performance, although the qCSI had similar efficacy by evaluating only three items. However, the NEWS, already widely validated in clinical practice, had a similar performance and could be appropriate for older patients with COVID-19. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; COVID-GRAM; ISARIC-4C; NEWS; qCSI.
 
Back
Top Bottom